ARCHIVES

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

This article is from The Cancer Letter archive.

Vol. 37 No. 22 | June 3, 2011

Download PDF Visit The Full Archive

Related Articles

1985 International Cancer Congress to Be In Budapest

September 24, 1982

In Brief: House, Senate Differ On NCI Positions; Upton Says Viral Oncology research Will Be Continued

August 12, 1977

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

May 31, 2013

“I Can’t Permit Destruction of NSABP,” Fisher Writes

September 9, 1994

Program Announcement On Effects Of Low Dose Radiation

October 2, 1981

NTP Establishes Panel To Write New Guidelines For Detection, Evaluation Of Chemical Carcinogens

April 1, 1983